Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_provenance.
- NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_assertion description "[The negative effects of cyclin G2 on cell cycle and cell proliferation, which occur without altering p27(Kip1) levels, may contribute to the ability of trastuzumab to inhibit breast cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_provenance.
- NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_assertion evidence source_evidence_literature NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_provenance.
- NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_assertion SIO_000772 18025271 NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_provenance.
- NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_assertion wasDerivedFrom befree-2016 NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_provenance.
- NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_assertion wasGeneratedBy ECO_0000203 NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_provenance.
- befree-2016 importedOn "2016-02-19" NP641227.RA7Up9EiSKF-DEhfZx17M2m-bXcKCBmHqgBx2ZQJkVBVM130_provenance.